Literature DB >> 6389357

A role for rheumatoid factor enhancement of Plasmodium falciparum schizont inhibition in vitro.

T J Green, B J Packer.   

Abstract

Studies were undertaken to determine whether rheumatoid factor (RF) was present in immune human and Aotus trivirgatus monkey sera which inhibited Plasmodium falciparum schizonts in vitro and to determine whether RF could be responsible for or contribute to merozoite agglutination in the parasite inhibition test. Additional studies were conducted to determine the effect of exogenous RF on schizont inhibition when used alone or in conjunction with immune or normal sera. RF was not detected in any of the 11 immune monkey sera or the 3 immune human sera which were tested. However, when RF was added to immune human or Aotus sera, levels of schizont inhibition increased significantly over levels obtained with immune serum alone. When RF was used alone or in conjunction with normal sera, levels of schizont inhibition were comparable to those obtained with normal serum. Furthermore, adsorption of the RF with immunoglobulin G-coated erythrocytes removed the enhancing activity. The results of this study indicate that RF, which is sometimes produced during acute or chronic malarial infection, may contribute nonspecifically to the enhanced clearance of plasmodia in vivo.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389357      PMCID: PMC261594          DOI: 10.1128/iai.46.3.668-672.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Rheumatoid factors and Chagas' disease.

Authors:  H R Cabral
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

2.  Mechanism of removal of senescent cells by human macrophages in situ.

Authors:  M M Kay
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Autoimmune reactions in rats with Plasmodium berghei infection.

Authors:  J Kreier; H Shapiro; D Dilley; I P Szilvassy; M Ristic
Journal:  Exp Parasitol       Date:  1966-10       Impact factor: 2.011

4.  Patterns of antibody and serum proteins in experimentally induced human malaria.

Authors:  W E Collins; P G Contacos; J C Skinner; A J Harrison; L S Gell
Journal:  Trans R Soc Trop Med Hyg       Date:  1971       Impact factor: 2.184

5.  Effect of different reagents on lysis of Salmonella typhosa.

Authors:  M M Nasir; S Ghatak
Journal:  Indian J Med Res       Date:  1970-01       Impact factor: 2.375

6.  Culture of Plasmodium falciparum in vitro: a subculture technique used for demonstrating antiplasmodial activity in serum from some Gambians, resident in an endemic malarious area.

Authors:  R S Phillips; P I Trigg; T J Scott-Finnigan; R K Bartholomew
Journal:  Parasitology       Date:  1972-12       Impact factor: 3.234

7.  Mechanisms of erythrocyte destruction in chickens infected with Plasmodium gallinaceum.

Authors:  J P Kreier
Journal:  Mil Med       Date:  1969-09       Impact factor: 1.437

8.  Action of malarial antibody in vitro.

Authors:  S Cohen; G A Butcher; R B Crandall
Journal:  Nature       Date:  1969-07-26       Impact factor: 49.962

9.  Erythrocyte membrane-associated immunoglobulins during malaria infection of mice.

Authors:  H J Lustig; V Nussenzweig; R S Nussenzweig
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

10.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

View more
  3 in total

1.  The prevalence of autoantibodies in an elderly sub-Saharan African population.

Authors:  R Njemini; I Meyers; C Demanet; J Smitz; M Sosso; T Mets
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Plasmodium berghei malaria: effects of acute-phase serum and erythrocyte-bound immunoglobulins on erythrophagocytosis by rat peritoneal macrophages.

Authors:  B J Packer; J P Kreier
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

Review 3.  Neutralization-Enhancing RF Antibodies for HIV Vaccines.

Authors:  Konstantin V Suslov
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.